Birds Hill Pharmaceutical, Inc. — TTAB Proceedings
Birds Hill Pharmaceutical, Inc. is a party to 2 TTAB proceedings.
Proceedings
- Proceeding 91150104 — Oppositions, Terminated (filed 2001-08-08) against METAGENICS, INC. as defendant
- Proceeding 75896383 — Extensions of Time to Oppose, Terminated (filed —) against Elan Pharmaceuticals, Inc. as defendant
Marks in These TTAB Matters
Common TTAB Counterparties
- Elan Pharmaceuticals, Inc. — 1 proceedings
- METAGENICS, INC. — 1 proceedings
Recent TTAB Timeline
- 2002-08-26: 91150104 — SUBMITTED ON BRIEF involving METAGENICS, INC.
- 2002-08-15: 75896383 — DELETE ENTRY involving Elan Pharmaceuticals, Inc.
- 2002-02-19: 91150104 — TERMINATED involving METAGENICS, INC.
- 2002-02-19: 91150104 — TERMINATED involving METAGENICS, INC.
- 2002-02-19: 91150104 — BOARD'S DECISION: SUSTAINED involving METAGENICS, INC.
- 2002-01-30: 75896383 — EXTENSION OF TIME GRANTED involving Elan Pharmaceuticals, Inc.
- 2002-01-10: 75896383 — EXTENSION OF TIME GRANTED involving Elan Pharmaceuticals, Inc.
- 2001-12-26: 75896383 — INCOMING - EXT TIME TO OPPOSE FILED involving Elan Pharmaceuticals, Inc.
- 2001-12-13: 91150104 — NOTICE OF DEFAULT involving METAGENICS, INC.
- 2001-11-13: 75896383 — INCOMING - EXT TIME TO OPPOSE FILED involving Elan Pharmaceuticals, Inc.
- 2001-10-11: 75896383 — EXTENSION OF TIME GRANTED involving Elan Pharmaceuticals, Inc.
- 2001-09-26: 91150104 — PENDING, INSTITUTED involving METAGENICS, INC.
- 2001-09-26: 91150104 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving METAGENICS, INC.
- 2001-09-24: 75896383 — EXTENSION OF TIME GRANTED involving Elan Pharmaceuticals, Inc.
- 2001-09-10: 75896383 — INCOMING - EXT TIME TO OPPOSE FILED involving Elan Pharmaceuticals, Inc.
- 2001-08-16: 75896383 — EXTENSION OF TIME GRANTED involving Elan Pharmaceuticals, Inc.
- 2001-08-08: 91150104 — FILED AND FEE involving METAGENICS, INC.
- 2001-08-06: 75896383 — INCOMING - EXT TIME TO OPPOSE FILED involving Elan Pharmaceuticals, Inc.
- 2001-07-02: 75896383 — INCOMING - EXT TIME TO OPPOSE FILED involving Elan Pharmaceuticals, Inc.